Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data

20 Jun 2019

Abstract excerpt

BACKGROUND: Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-related genes of influence, which can be identified as responsive targets for reliable treatment. METHOD: In this study, we used a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Cutaneous Melanoma Detection and Management
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31221082
DOI: 10.1186/s10020-019-0098-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics dataPMID 31221082Read ↗

Systematic review and network meta-analysis of drug combinations suggested by machine learning on genes and proteins, with the aim of improving the effectiveness of Ipilimumab in treating MelanomaSemantic proximity Read ↗

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target PredictionSemantic proximity Read ↗

Identification of Potential Hub Genes and Pathways Predicting Pathogenesis in Skin Cutaneous MelanomaSemantic proximity Read ↗

Investigation of the mechanism of the anti-cancer effects of Astragalus propinquus Schischkin and Pinellia pedatisecta Schott (A&P) on melanoma via network pharmacology and experimental verificationSemantic proximity Read ↗

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy ResponseSemantic proximity Read ↗

Finding melanoma drugs through a probabilistic knowledge graphSemantic proximity Read ↗

Multi-omics construction of prognostic and immunotherapy-related gene signature and small molecule drug prediction for skin cutaneous melanomaSemantic proximity Read ↗

Identification of potential therapeutic targets for skin cutaneous melanoma on the basic of transcriptomics.Semantic proximity Read ↗

Single-cell RNA-sequencing analyses along with abundant machine learning methods develop and validate a novel metabolism-related prognostic model in SKCMSemantic proximity Read ↗

Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysisSemantic proximity Read ↗

Identification of a cuproptosis-associated gene signature and Peptidylprolyl isomerase C as therapeutic target in cutaneous melanomaSemantic proximity Read ↗

The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.